Global Nerve Repair and Regeneration Market- Industry Analysis, Growth, Segmentation and Forecast-2020-2027

The Global market for Nerve Repair and Regeneration was valued at $xx Mn in 2020 and is expected to reach $xx Mn by 2027, at a CAGR of xx%. The prevalence of neurological disorders and chronic pain is increasing rapidly across the globe. Depression, epilepsy, Parkinson’s, and Alzheimer’s are different kinds of neurological disorders. As per the Alzheimer’s Association, about 5.35 million people aged 65 years and above were suffering from Alzheimer’s diseases in the U.S. in 2015. Apart from this, as per the Parkinson’s Diseases Foundation, nearly 60,000 new cases of Parkinson’s disease are reported each year in the U.S. Due to these reasons, the demand for efficient medical technologies, such as Neuromodulation and Neurostimulation devices are increasing rapidly. Furthermore, the nerve repair and regeneration market are witnessing significant growth due to the increasing geriatric population. The generation of the new axon, glial cells, neurons, and myelin is referred to as nerve repair and regeneration. The process helps in the replacement of damaged nerve cells, cellular products, and tissues. Neurostimulation & Neuromodulation devices and biomaterials are the products that are utilized for reversing the damage caused to the nerve. Between these two, the largest demand is expected to be created for Neurostimulation and Neuromodulation devices in the coming years, due to increasing incidences of peripheral nerve injuries, favorable reimbursement policies, and technological advancements. Availability of a number of therapies for treating various Central Nervous System (CNS) disorders, such as Parkinson’s disease and Alzheimer’s, and increasing scope of applications is further expected to boost the market growth over the forecast period. Increasing awareness, environmental influence, lifestyle, genetics, nutrition are some of the factors that can cause such disorders. The report contains detailed analysis of Strengths, Weakness and opportunities of the key players operating in the Nerve Repair and Regeneration Market. It also provides information on current market trends, competitive ranking analysis, regional bifurcation, turnover forecasts, industry drivers and the key challenges. The report has profiled twenty key players in the market from different regions. However, report has considered all market leaders, followers and new entrants with investors while analysing the market and estimation the size of the same. The growing healthcare infrastructure in each region is different and focus is given on availability of advanced technology and new techniques.

Global Nerve Repair and Regeneration Market Segment Analysis

Neurostimulation and Neuromodulation Devices held the largest share of xx% in 2020 Based on the product, the market is segmented as Neurostimulation and Neuromodulation Devices. The segment is further sub-segmented into internal Neurostimulation and external Neurostimulation devices and biomaterials. Neurostimulation and Neuromodulation Devices was the largest segment which held a significant share of xx% in 2020 and is expected to grow at a CAGR of xx%. The largely available spinal cord products and a wider range of applications for the same were responsible for the market growth. The internal Neurostimulation devices segment is again segmented into- Spinal Cord Stimulation (SCS), Deep Brain Stimulation (DBS), Vagus Nerve Stimulation (VNS), Sacral Nerve Stimulation (SNS), Gastric Electrical Stimulation (GES). The segment growth for internal Neurostimulation devices is expected to boost in the forecast period. Investments of top players of the market in the new launching of more advanced devices is a major driver for the Neurostimulation and Neuromodulation Devices market. On 23 July 2020, the US Food and Drug Administration (FDA) approved Abbott's Patient Controller App’ on compatible personal Apple smartphone devices. According to Abbott, this approval allows patients living with neurological conditions, including chronic pain or movement disorders, the ability to manage therapy directly from their personal smartphone. Such advancements are boosting the market growth. Based on applications, the Stem cell therapy segment is expected to witness the fastest CAGR due to the various government initiatives and approvals to conduct clinical trials of biomaterials. A high number of research centers, universities, and companies, from European nations, the United States, and Canada, are also conducting several clinical trials for the application of stem cell-based therapies in nerve repair and regeneration. These countries are found to be backed by high government funding, well-developed healthcare infrastructure, and widespread global presence. Due to the above factors, the segment is expected to show a growth market over the forecast period.

Scope of the Global Nerve Repair and Regeneration Market : Inquire before buying

Global Nerve Repair and Regeneration Market Segmentation

The Global Nerve Repair and Regeneration Market is segmented based on-

Global Nerve Repair and Regeneration Market Product

• Neurostimulation and Neuromodulation Devices  Internal Neurostimulation Devices  Spinal Cord Stimulation (SCS)  Deep Brain Stimulation (DBS)  Vagus Nerve Stimulation (VNS)  Sacral Nerve Stimulation (SNS)  Gastric Electrical Stimulation (GES)  External Neurostimulation Devices  TENS  TMS  RES  Biomaterials  Nerve Conduits  Nerve Wraps

Global Nerve Repair and Regeneration Market Applications

• Neurostimulation and Neuromodulation Applications  Internal Neurostimulation and Neuromodulation Applications  External Neurostimulation and Neuromodulation Applications • Direct Nerve Repair/Neurorrhaphy  Epineural Repair  Perineural Repair  Group Fascicular Repair • Nerve Grafting  Auto grafts  Allografts  Xeno grafts • Stem Cell Therapy Global Nerve Repair and Regeneration Market To know about the Research Methodology :- Request Free Sample Report

Global Nerve Repair and Regeneration Market Regional Insights

Global Nerve Repair and Regeneration Market1 North America accounted for the largest share of Global Nerve Repair and Regeneration Market in 2020 North America accounted for the largest share of xx% in 2020, the reason being the rising prevalence of neural disorders. Growth in insurance coverage in the U.S. has increased the burden on the country’s healthcare system, which has highlighted the need for improving efficiency and management of work in North America. Investments by key players in this field have boosted the market growth. For instance, on December 24, 2020, Soterix Medical announced expanded clinical trials of its transcranial direct current stimulation system in Alzheimer’s disease. Asia Pacific is also expected to witness significant growth during the forecast period due to the increasing geriatric population and rising health care expenditures. The allocation of a large amount of healthcare expenditure for hospitals and dispensing medicines to the elderly is expected to drive the market demand.

Key Players operating in the Global Nerve Repair and Regeneration Market

• Medtronic, PLC • Boston Scientific Corporation • Abbott Laboratories • AxoGen, Inc • Baxter International • LivaNova, PLC • Integra Lifesciences • Polyganics • NeuroPace • Soterix Medical, Inc • Nvero Corp • Synapse Biomedical, Inc • Aleva Neurotherapeutics • Collagen Matrix • KeriMedical • BioWave Corporation • NeuroSigma • tVNS Technologies GmbH • GiMer Medical The report also helps in understanding Global Nerve Repair and Regeneration Market dynamics, structure by analysing the market segments and project Global Nerve Repair and Regeneration Market size. Clear representation of competitive analysis of key players by product, price, financial position, product portfolio, growth strategies, and regional presence in the Global Nerve Repair and Regeneration Market make the report investor’s guide.
Global Nerve Repair and Regeneration Market 1. Preface 1.1. Report Scope and Market Segmentation 1.2. Research Highlights 1.3. Research Objectives 2. Assumptions and Research Methodology 2.1. Report Assumptions 2.2. Abbreviations 2.3. Research Methodology 2.3.1. Secondary Research 2.3.1.1. Secondary data 2.3.1.2. Secondary Sources 2.3.2. Primary Research 2.3.2.1. Data from Primary Sources 2.3.2.2. Breakdown of Primary Sources 3. Executive Summary: NERVE REPAIR AND REGENERATION Market Size, By Market Value (US$ Mn) 4. Market Overview 4.1. Introduction 4.2. Market Indicator 4.2.1. Drivers 4.2.2. Restraints 4.2.3. Opportunities 4.2.4. Challenges 4.3. Porter’s Analysis 4.4. Value Chain Analysis 4.5. Market Risk Analysis 4.6. SWOT Analysis 4.7. Industry Trends and Emerging Technologies 5. Supply Side and Demand Side Indicators 6. Global NERVE REPAIR AND REGENERATION Market Analysis and Forecast 6.1. NERVE REPAIR AND REGENERATION Market Size & Y-o-Y Growth Analysis 6.1.1. North America 6.1.2. Europe 6.1.3. Asia Pacific 6.1.4. Middle East & Africa 6.1.5. South America 7. Global NERVE REPAIR AND REGENERATION Market Analysis and Forecast, By Product 7.1. Introduction and Definition 7.2. Key Findings 7.3. NERVE REPAIR AND REGENERATION Market Value Share Analysis, By Product 7.4. NERVE REPAIR AND REGENERATION Market Size (US$ Mn) Forecast, By Product 7.5. NERVE REPAIR AND REGENERATION Market Analysis, By Product 7.6. NERVE REPAIR AND REGENERATION Market Attractiveness Analysis, By Product 8. Global NERVE REPAIR AND REGENERATION Market Analysis and Forecast, By Applications 8.1. Introduction and Definition 8.2. Key Findings 8.3. NERVE REPAIR AND REGENERATION Market Value Share Analysis, By Applications 8.4. NERVE REPAIR AND REGENERATION Market Size (US$ Mn) Forecast, By Applications 8.5. NERVE REPAIR AND REGENERATION Market Analysis, By Applications 8.6. NERVE REPAIR AND REGENERATION Market Attractiveness Analysis, By Applications 9. Global NERVE REPAIR AND REGENERATION Market Analysis, By Region 9.1. NERVE REPAIR AND REGENERATION Market Value Share Analysis, By Region 9.2. NERVE REPAIR AND REGENERATION Market Size (US$ Mn) Forecast, By Region 9.3. NERVE REPAIR AND REGENERATION Market Attractiveness Analysis, By Region 10. North America NERVE REPAIR AND REGENERATION Market Analysis 10.1. Key Findings 10.2. North America NERVE REPAIR AND REGENERATION Market Overview 10.3. North America NERVE REPAIR AND REGENERATION Market Value Share Analysis, By Product 10.4. North America NERVE REPAIR AND REGENERATION Market Forecast, By Product 10.4.1. Neurostimulation and Neuromodulation Devices 10.5. North America NERVE REPAIR AND REGENERATION Market Value Share Analysis, By Applications 10.6. North America NERVE REPAIR AND REGENERATION Market Forecast, By Applications 10.6.1. Neurostimulation and Neuromodulation Applications 10.6.2. Direct Nerve Repair/Neurorrhaphy 10.6.3. Nerve Grafting 10.6.4. Stem Cell Therapy 10.7. North America NERVE REPAIR AND REGENERATION Market Value Share Analysis, By Country 10.8. North America NERVE REPAIR AND REGENERATION Market Forecast, By Country 10.8.1. U.S. 10.8.2. Canada 10.8.3. Mexico 10.9. North America NERVE REPAIR AND REGENERATION Market Analysis, By Country 10.10. U.S. NERVE REPAIR AND REGENERATION Market Forecast, By Product 10.10.1. Neurostimulation and Neuromodulation Devices 10.11. U.S. NERVE REPAIR AND REGENERATION Market Forecast, By Applications 10.11.1. Neurostimulation and Neuromodulation Applications 10.11.2. Direct Nerve Repair/Neurorrhaphy 10.11.3. Nerve Grafting 10.11.4. Stem Cell Therapy 10.12. Canada NERVE REPAIR AND REGENERATION Market Forecast, By Product 10.12.1. Neurostimulation and Neuromodulation Devices 10.13. Canada NERVE REPAIR AND REGENERATION Market Forecast, By Applications 10.13.1. Neurostimulation and Neuromodulation Applications 10.13.2. Direct Nerve Repair/Neurorrhaphy 10.13.3. Nerve Grafting 10.13.4. Stem Cell Therapy 10.14. Mexico NERVE REPAIR AND REGENERATION Market Forecast, By Product 10.14.1. Neurostimulation and Neuromodulation Devices 10.15. Mexico NERVE REPAIR AND REGENERATION Market Forecast, By Applications 10.15.1. Neurostimulation and Neuromodulation Applications 10.15.2. Direct Nerve Repair/Neurorrhaphy 10.15.3. Nerve Grafting 10.15.4. Stem Cell Therapy 10.16. North America NERVE REPAIR AND REGENERATION Market Attractiveness Analysis 10.16.1. By Product 10.16.2. By Applications 10.17. PEST Analysis 10.18. Key Trends 10.19. Key Developments 11. Europe NERVE REPAIR AND REGENERATION Market Analysis 11.1. Key Findings 11.2. Europe NERVE REPAIR AND REGENERATION Market Overview 11.3. Europe NERVE REPAIR AND REGENERATION Market Value Share Analysis, By Product 11.4. Europe NERVE REPAIR AND REGENERATION Market Forecast, By Product 11.4.1. Neurostimulation and Neuromodulation Devices 11.5. Europe NERVE REPAIR AND REGENERATION Market Value Share Analysis, By Applications 11.6. Europe NERVE REPAIR AND REGENERATION Market Forecast, By Applications 11.6.1. Neurostimulation and Neuromodulation Applications 11.6.2. Direct Nerve Repair/Neurorrhaphy 11.6.3. Nerve Grafting 11.6.4. Stem Cell Therapy 11.7. Europe NERVE REPAIR AND REGENERATION Market Value Share Analysis, By Country 11.8. Europe NERVE REPAIR AND REGENERATION Market Forecast, By Country 11.8.1. Germany 11.8.2. U.K. 11.8.3. France 11.8.4. Italy 11.8.5. Spain 11.8.6. Sweden 11.8.7. CIS countries 11.8.8. Rest of Europe 11.9. Germany NERVE REPAIR AND REGENERATION Market Forecast, By Product 11.9.1. Neurostimulation and Neuromodulation Devices 11.10. Germany NERVE REPAIR AND REGENERATION Market Forecast, By Applications 11.10.1. Neurostimulation and Neuromodulation Applications 11.10.2. Direct Nerve Repair/Neurorrhaphy 11.10.3. Nerve Grafting 11.10.4. Stem Cell Therapy 11.11. U.K. NERVE REPAIR AND REGENERATION Market Forecast, By Product 11.11.1. Neurostimulation and Neuromodulation Devices 11.12. U.K. NERVE REPAIR AND REGENERATION Market Forecast, By Applications 11.12.1. Neurostimulation and Neuromodulation Applications 11.12.2. Direct Nerve Repair/Neurorrhaphy 11.12.3. Nerve Grafting 11.12.4. Stem Cell Therapy 11.13. France NERVE REPAIR AND REGENERATION Market Forecast, By Product 11.13.1. Neurostimulation and Neuromodulation Devices 11.14. France NERVE REPAIR AND REGENERATION Market Forecast, By Applications 11.14.1. Neurostimulation and Neuromodulation Applications 11.14.2. Direct Nerve Repair/Neurorrhaphy 11.14.3. Nerve Grafting 11.14.4. Stem Cell Therapy 11.15. Italy NERVE REPAIR AND REGENERATION Market Forecast, By Product 11.15.1. Neurostimulation and Neuromodulation Devices 11.16. Italy NERVE REPAIR AND REGENERATION Market Forecast, By Applications 11.16.1. Neurostimulation and Neuromodulation Applications 11.16.2. Direct Nerve Repair/Neurorrhaphy 11.16.3. Nerve Grafting 11.16.4. Stem Cell Therapy 11.17. Spain NERVE REPAIR AND REGENERATION Market Forecast, By Product 11.17.1. Neurostimulation and Neuromodulation Devices 11.18. Spain NERVE REPAIR AND REGENERATION Market Forecast, By Applications 11.18.1. Neurostimulation and Neuromodulation Applications 11.18.2. Direct Nerve Repair/Neurorrhaphy 11.18.3. Nerve Grafting 11.18.4. Stem Cell Therapy 11.19. Sweden NERVE REPAIR AND REGENERATION Market Forecast, By Product 11.19.1. Neurostimulation and Neuromodulation Devices 11.20. Sweden NERVE REPAIR AND REGENERATION Market Forecast, By Applications 11.20.1. Neurostimulation and Neuromodulation Applications 11.20.2. Direct Nerve Repair/Neurorrhaphy 11.20.3. Nerve Grafting 11.20.4. Stem Cell Therapy 11.21. CIS countries NERVE REPAIR AND REGENERATION Market Forecast, By Product 11.21.1. Neurostimulation and Neuromodulation Devices 11.22. CIS countries NERVE REPAIR AND REGENERATION Market Forecast, By Applications 11.22.1. Neurostimulation and Neuromodulation Applications 11.22.2. Direct Nerve Repair/Neurorrhaphy 11.22.3. Nerve Grafting 11.22.4. Stem Cell Therapy 11.23. Rest of Europe NERVE REPAIR AND REGENERATION Market Forecast, By Product 11.23.1. Neurostimulation and Neuromodulation Devices 11.24. Rest of Europe NERVE REPAIR AND REGENERATION Market Forecast, By Applications 11.24.1. Neurostimulation and Neuromodulation Applications 11.24.2. Direct Nerve Repair/Neurorrhaphy 11.24.3. Nerve Grafting 11.24.4. Stem Cell Therapy 11.25. Europe NERVE REPAIR AND REGENERATION Market Attractiveness Analysis 11.25.1. By Applications 11.25.2. By Product 11.26. PEST Analysis 11.27. Key Trends 11.28. Key Developments 12. Asia Pacific NERVE REPAIR AND REGENERATION Market Analysis 12.1. Key Findings 12.2. Asia Pacific NERVE REPAIR AND REGENERATION Market Overview 12.3. Asia Pacific NERVE REPAIR AND REGENERATION Market Value Share Analysis, By Product 12.4. Asia Pacific NERVE REPAIR AND REGENERATION Market Forecast, By Product 12.4.1. Neurostimulation and Neuromodulation Devices 12.5. Asia Pacific NERVE REPAIR AND REGENERATION Market Value Share Analysis, By Applications 12.6. Asia Pacific NERVE REPAIR AND REGENERATION Market Forecast, By Applications 12.6.1. Neurostimulation and Neuromodulation Applications 12.6.2. Direct Nerve Repair/Neurorrhaphy 12.6.3. Nerve Grafting 12.6.4. Stem Cell Therapy 12.7. Asia Pacific NERVE REPAIR AND REGENERATION Market Value Share Analysis, By Country 12.8. Asia Pacific NERVE REPAIR AND REGENERATION Market Forecast, By Country 12.8.1. China 12.8.2. India 12.8.3. Japan 12.8.4. South Korea 12.8.5. Australia 12.8.6. ASEAN 12.8.7. Rest of Asia Pacific 12.9. Asia Pacific NERVE REPAIR AND REGENERATION Market Analysis, By Country 12.10. China NERVE REPAIR AND REGENERATION Market Forecast, By Product 12.10.1. Neurostimulation and Neuromodulation Devices 12.11. China NERVE REPAIR AND REGENERATION Market Forecast, By Applications 12.11.1. Neurostimulation and Neuromodulation Applications 12.11.2. Direct Nerve Repair/Neurorrhaphy 12.11.3. Nerve Grafting 12.11.4. Stem Cell Therapy 12.12. India NERVE REPAIR AND REGENERATION Market Forecast, By Product 12.12.1. Neurostimulation and Neuromodulation Devices 12.13. India NERVE REPAIR AND REGENERATION Market Forecast, By Applications 12.13.1. Neurostimulation and Neuromodulation Applications 12.13.2. Direct Nerve Repair/Neurorrhaphy 12.13.3. Nerve Grafting 12.13.4. Stem Cell Therapy 12.14. Japan NERVE REPAIR AND REGENERATION Market Forecast, By Product 12.14.1. Neurostimulation and Neuromodulation Devices 12.15. Japan NERVE REPAIR AND REGENERATION Market Forecast, By Applications 12.15.1. Neurostimulation and Neuromodulation Applications 12.15.2. Direct Nerve Repair/Neurorrhaphy 12.15.3. Nerve Grafting 12.15.4. Stem Cell Therapy 12.16. South Korea NERVE REPAIR AND REGENERATION Market Forecast, By Product 12.16.1. Neurostimulation and Neuromodulation Devices 12.17. South Korea NERVE REPAIR AND REGENERATION Market Forecast, By Applications 12.17.1. Neurostimulation and Neuromodulation Applications 12.17.2. Direct Nerve Repair/Neurorrhaphy 12.17.3. Nerve Grafting 12.17.4. Stem Cell Therapy 12.18. Australia NERVE REPAIR AND REGENERATION Market Forecast, By Product 12.18.1. Neurostimulation and Neuromodulation Devices 12.19. Australia NERVE REPAIR AND REGENERATION Market Forecast, By Applications 12.19.1. Neurostimulation and Neuromodulation Applications 12.19.2. Direct Nerve Repair/Neurorrhaphy 12.19.3. Nerve Grafting 12.19.4. Stem Cell Therapy 12.20. ASEAN NERVE REPAIR AND REGENERATION Market Forecast, By Product 12.20.1. Neurostimulation and Neuromodulation Devices 12.21. ASEAN NERVE REPAIR AND REGENERATION Market Forecast, By Applications 12.21.1. Neurostimulation and Neuromodulation Applications 12.21.2. Direct Nerve Repair/Neurorrhaphy 12.21.3. Nerve Grafting 12.21.4. Stem Cell Therapy 12.22. Rest of Asia Pacific NERVE REPAIR AND REGENERATION Market Forecast, By Product 12.22.1. Neurostimulation and Neuromodulation Devices 12.23. Rest of Asia Pacific NERVE REPAIR AND REGENERATION Market Forecast, By Applications 12.23.1. Neurostimulation and Neuromodulation Applications 12.23.2. Direct Nerve Repair/Neurorrhaphy 12.23.3. Nerve Grafting 12.23.4. Stem Cell Therapy 12.24. Asia Pacific NERVE REPAIR AND REGENERATION Market Attractiveness Analysis 12.24.1. By Product 12.24.2. By Applications 12.25. PEST Analysis 12.26. Key Trends 12.27. Key Developments 13. Middle East & Africa NERVE REPAIR AND REGENERATION Market Analysis 13.1. Key Findings 13.2. Middle East & Africa NERVE REPAIR AND REGENERATION Market Overview 13.3. Middle East & Africa NERVE REPAIR AND REGENERATION Market Value Share Analysis, By Product 13.4. Middle East & Africa NERVE REPAIR AND REGENERATION Market Forecast, By Product 13.4.1. Neurostimulation and Neuromodulation Devices 13.5. Middle East & Africa NERVE REPAIR AND REGENERATION Market Value Share Analysis, By Applications 13.6. Middle East & Africa NERVE REPAIR AND REGENERATION Market Forecast, By Applications 13.6.1. Neurostimulation and Neuromodulation Applications 13.6.2. Direct Nerve Repair/Neurorrhaphy 13.6.3. Nerve Grafting 13.6.4. Stem Cell Therapy 13.7. Middle East & Africa NERVE REPAIR AND REGENERATION Market Value Share Analysis, By Country 13.8. Middle East & Africa NERVE REPAIR AND REGENERATION Market Forecast, By Country 13.8.1. GCC Countries 13.8.2. South Africa 13.8.3. Nigeria 13.8.4. Egypt 13.8.5. Rest of Middle East & Africa 13.9. Middle East & Africa NERVE REPAIR AND REGENERATION Market Analysis, By Country 13.10. GCC Countries NERVE REPAIR AND REGENERATION Market Forecast, By Product 13.10.1. Neurostimulation and Neuromodulation Devices 13.11. GCC Countries NERVE REPAIR AND REGENERATION Market Forecast, By Applications 13.11.1. Neurostimulation and Neuromodulation Applications 13.11.2. Direct Nerve Repair/Neurorrhaphy 13.11.3. Nerve Grafting 13.11.4. Stem Cell Therapy 13.12. South Africa NERVE REPAIR AND REGENERATION Market Forecast, By Product 13.12.1. Neurostimulation and Neuromodulation Devices 13.13. South Africa NERVE REPAIR AND REGENERATION Market Forecast, By Applications 13.13.1. Neurostimulation and Neuromodulation Applications 13.13.2. Direct Nerve Repair/Neurorrhaphy 13.13.3. Nerve Grafting 13.13.4. Stem Cell Therapy 13.14. Nigeria NERVE REPAIR AND REGENERATION Market Forecast, By Product 13.14.1. Neurostimulation and Neuromodulation Devices 13.15. Nigeria NERVE REPAIR AND REGENERATION Market Forecast, By Applications 13.15.1. Neurostimulation and Neuromodulation Applications 13.15.2. Direct Nerve Repair/Neurorrhaphy 13.15.3. Nerve Grafting 13.15.4. Stem Cell Therapy 13.16. Egypt NERVE REPAIR AND REGENERATION Market Forecast, By Product 13.16.1. Neurostimulation and Neuromodulation Devices 13.17. Egypt NERVE REPAIR AND REGENERATION Market Forecast, By Applications 13.17.1. Neurostimulation and Neuromodulation Applications 13.17.2. Direct Nerve Repair/Neurorrhaphy 13.17.3. Nerve Grafting 13.17.4. Stem Cell Therapy 13.18. Rest of Middle East & Africa NERVE REPAIR AND REGENERATION Market Forecast, By Product 13.18.1. Neurostimulation and Neuromodulation Devices 13.19. Rest of Middle East & Africa NERVE REPAIR AND REGENERATION Market Forecast, By Applications 13.19.1. Neurostimulation and Neuromodulation Applications 13.19.2. Direct Nerve Repair/Neurorrhaphy 13.19.3. Nerve Grafting 13.19.4. Stem Cell Therapy 13.20. Middle East & Africa NERVE REPAIR AND REGENERATION Market Attractiveness Analysis 13.20.1. By Product 13.20.2. By Applications 13.21. PEST Analysis 13.22. Key Trends 13.23. Key Developments 14. South America NERVE REPAIR AND REGENERATION Market Analysis 14.1. Key Findings 14.2. South America NERVE REPAIR AND REGENERATION Market Overview 14.3. South America NERVE REPAIR AND REGENERATION Market Value Share Analysis, By Product 14.4. South America NERVE REPAIR AND REGENERATION Market Forecast, By Product 14.4.1. Neurostimulation and Neuromodulation Devices 14.5. South America NERVE REPAIR AND REGENERATION Market Value Share Analysis, By Applications 14.6. South America NERVE REPAIR AND REGENERATION Market Forecast, By Applications 14.6.1. Neurostimulation and Neuromodulation Applications 14.6.2. Direct Nerve Repair/Neurorrhaphy 14.6.3. Nerve Grafting 14.6.4. Stem Cell Therapy 14.7. South America NERVE REPAIR AND REGENERATION Market Value Share Analysis, By Country 14.8. South America NERVE REPAIR AND REGENERATION Market Forecast, By Country 14.8.1. Brazil 14.8.2. Colombia 14.8.3. Argentina 14.8.4. Rest of South America 14.9. South America NERVE REPAIR AND REGENERATION Market Analysis, By Country 14.10. Brazil NERVE REPAIR AND REGENERATION Market Forecast, By Product 14.10.1. Neurostimulation and Neuromodulation Devices 14.11. Brazil NERVE REPAIR AND REGENERATION Market Forecast, By Applications 14.11.1. Neurostimulation and Neuromodulation Applications 14.11.2. Direct Nerve Repair/Neurorrhaphy 14.11.3. Nerve Grafting 14.11.4. Stem Cell Therapy 14.12. Colombia NERVE REPAIR AND REGENERATION Market Forecast, By Product 14.12.1. Neurostimulation and Neuromodulation Devices 14.13. Colombia NERVE REPAIR AND REGENERATION Market Forecast, By Applications 14.13.1. Neurostimulation and Neuromodulation Applications 14.13.2. Direct Nerve Repair/Neurorrhaphy 14.13.3. Nerve Grafting 14.13.4. Stem Cell Therapy 14.14. Argentina NERVE REPAIR AND REGENERATION Market Forecast, By Product 14.14.1. Neurostimulation and Neuromodulation Devices 14.15. Argentina NERVE REPAIR AND REGENERATION Market Forecast, By Applications 14.15.1. Neurostimulation and Neuromodulation Applications 14.15.2. Direct Nerve Repair/Neurorrhaphy 14.15.3. Nerve Grafting 14.15.4. Stem Cell Therapy 14.16. Rest of South America NERVE REPAIR AND REGENERATION Market Forecast, By Product 14.16.1. Neurostimulation and Neuromodulation Devices 14.17. Rest of South America NERVE REPAIR AND REGENERATION Market Forecast, By Applications 14.17.1. Neurostimulation and Neuromodulation Applications 14.17.2. Direct Nerve Repair/Neurorrhaphy 14.17.3. Nerve Grafting 14.17.4. Stem Cell Therapy 14.18. South America NERVE REPAIR AND REGENERATION Market Attractiveness Analysis 14.18.1. By Product 14.18.2. By Applications 14.19. PEST Analysis 14.20. Key Trends 14.21. Key Developments 15. Company Profiles 15.1. Market Share Analysis, By Company 15.2. Competition Matrix 15.2.1. Competitive Benchmarking of key players By price, presence, market share, Applications, and R&D investment 15.2.2. New Product Launches and Product Enhancements 15.2.3. Market Consolidation 15.2.3.1. M&A By Regions, Investment and Applications 15.2.3.2. M&A Key Players, Forward Integration and Backward Integration 15.3. Company Profiles: Key Players 15.3.1. Medtronic, PLC 15.3.1.1. Company Overview 15.3.1.2. Financial Overview 15.3.1.3. Product Portfolio 15.3.1.4. Business Strategy 15.3.1.5. Recent Developments 15.3.1.6. Development Footprint 15.3.2. Boston Scientific Corporation 15.3.3. Abbott Laboratories 15.3.4. AxoGen, Inc 15.3.5. Baxter International 15.3.6. LivaNova, PLC 15.3.7. Integra Lifesciences 15.3.8. Polyganics 15.3.9. NeuroPace

About This Report

Report ID83571
Category Healthcare
Published DateFebruary 2021
Updated DateOct 2021
Contact Us